Debunking Ibogaine “Cure Rate” Claims (Why “80% Cured” Fails)

Definition box

Definition: Viral ibogaine success rate / ibogaine cure rate claims—especially “80% cured,” “one dose forever,” or “clinically proven remission”—are marketing and meme statistics, not FDA-labeled outcomes. Physician-supervised IV ibogaine infusion (psychoactive intravenous ibogaine) does not come with a guaranteed cure percentage for addiction, depression, or PTSD. Evidence gap: Most published clinical literature is oral observational or open-label (Cherian/MISTIC = oral ibogaine + IV magnesium support; Knuijver = oral QTc signals)—not controlled psychoactive-IV RCTs that could support a validated “cure rate.” Ibogaine can prolong the QTc interval. Ibogaine is U.S. Schedule I and not FDA-approved. No cure claims. Provisional Mexico programs discussed on this site are not FDA/US clinics.

Quotable answer (57 words)

There is no validated FDA-labeled ibogaine cure rate. Viral “80% cured” figures usually misuse small open-label or clinic anecdotes. IV ibogaine infusion is physician-supervised intravenous psychoactive ibogaine with cardiac monitoring; most published research remains oral-route. QTc risk is real. Relapse can occur. Treat guaranteed success percentages as a red flag.

The claim this page attacks

Search and social still recycle:

> “Ibogaine has an 80% success rate.” > “Studies show most people are cured after one flood.” > “Stanford proved it works for veterans—guaranteed.”

Those sentences fail on design, denominator, duration, route, and honesty. This article is deliberately anti-hype.

Condition pages that refuse cure language: /ibogaine-for-addiction · /ibogaine-for-depression · /ibogaine-for-ptsd.

Why small open-label series are not “cure rates”

1) No control group Open-label improvement can reflect expectancy, concurrent care, travel structure, selection of highly motivated patients, and regression to the mean—not only pharmacology.

2) Tiny N, special populations Cherian et al. (*Nature Medicine* 2024, MISTIC): on the order of **~30** special-operations veterans; **oral** ibogaine + **IV magnesium**; open-label; RCTs needed. Even if longer follow-up coverage appears, **label oral every time**—it still is not an IV psychoactive approval package or a population-wide cure rate.

3) Outcome definitions get fuzzy “Success” may mean short-term withdrawal relief, a self-report score change, or weeks without use—then get sold as lifelong cure. Addiction and depression are chronic, relapsing conditions for many people.

4) Lost-to-follow-up bias Clinic testimonials often track people who stay in touch and feel good—not everyone who relapsed and stopped answering.

5) Route laundry Oral observational outcomes get pasted onto **IV** ads. Support IV (fluids/Mg) gets sold as psychoactive IV proof. See /blog/ibogaine-oral-vs-iv · /blog/stanford-ibogaine-mistic · /blog/electrolytes-support-iv-vs-psychoactive-iv.

6) No FDA labeling Ibogaine is **not FDA-approved**. There is no labeled indication with a validated success percentage you can ethically quote like a package insert.

Mosca et al. systematic review posture: limited RCTs; cardiotoxicity concerns—exactly the opposite of viral certainty.

Cardiac reality vs success-rate theater

Cure-rate ads often bury the medical story. Ibogaine can prolong QTc and has been associated with serious cardiac events in the broader clinical conversation. Knuijver et al. (*Addiction*, 2021) reported clinically relevant QTc prolongation after oral ibogaine HCl in an open-label opioid-dependent cohort.

A clinic promising “80% cured” while treating ECG as optional is not evidence-based marketing—it is a safety red flag.

Read: /safety-and-screening · /blog/ibogaine-ecg-checklist · /blog/is-ibogaine-safe-screening-cardiac-risk · /blog/ibogaine-side-effects · /blog/ibogaine-contraindications.

No DIY dosing. Unsupervised use is dangerous regardless of Instagram percentages.

Red-flag clinic language (success-rate edition)

Walk away (or at least slow down hard) when you hear:

1. “Guaranteed detox / lifelong cure”
2. Exact success percentages with no peer-reviewed denominator, duration, or inclusion criteria
3. “Stanford/Nature Medicine proved our IV protocol” when MISTIC is oral + IV Mg
4. Pressure deposits before cardiac labs
5. Refusal to put psychoactive route in writing
6. “Same as FDA-approved” or “insurance will cover because 80%”

Full lists: /blog/cheap-ibogaine-clinic-red-flags · /blog/how-to-choose-an-ibogaine-clinic · Cost honesty: /blog/cost-of-ibogaine-treatment.

What honest outcome language sounds like

| Avoid | Prefer | |-------|--------| | “80% cured” | “Observational signals; RCTs needed; individual results vary” | | “One dose forever” | “Some people report short-term changes; relapse risk remains; aftercare matters” | | “Clinically proven IV cure” | “Psychoactive IV evidence is sparse; oral literature is mostly open-label” | | “Works for everyone” | “Contraindications and cardiac risk exclude many people” |

Aftercare matters precisely because no session is a guarantee: /blog/ibogaine-aftercare-integration (when published) · Program duration: /blog/ibogaine-program-duration.

How this site’s IV entity fits without fake stats

IV ibogaine infusion on ibogaineinfusion.com means psychoactive intravenous ibogaine under physician supervision (consult → screen → monitored infusion → integration). That entity lock is about route and medical model honesty, not a proprietary cure percentage.

Provisional Mexico availability for programs discussed on this site ≠ FDA/US clinic approval. Schedule I / not FDA-approved still frames U.S. consumer reality: /blog/is-ibogaine-legal-us.

How social media manufactures a percentage

A typical pipeline:

1. A facilitator recalls “most of our clients do well.”
2. Someone converts that memory into “80%.”
3. A landing page adds “clinically proven.”
4. A Reel strips the caveats.
5. A desperate searcher treats the meme as meta-analysis.

None of those steps is peer review. None survives basic questions: Who counted? For how long? What counted as success? Oral or IV? How many were lost to follow-up? How many had serious adverse events?

If a clinic cannot answer those in writing, the percentage is theater.

Addiction, depression, PTSD: why “cured” is the wrong word

Opioid use disorder Withdrawal interruption—even when dramatic—is not the same as durable recovery. Craving return, fentanyl contamination risk, and the need for ongoing care (including evidence-based MOUD conversations with clinicians) remain real. See /ibogaine-for-addiction · /blog/ibogaine-for-fentanyl · /blog/ibogaine-vs-methadone · /blog/ibogaine-vs-suboxone.

Depression Mood shifts after an intense experience can be meaningful **and** temporary. Treatment-resistant depression pages on this site refuse guarantee language: /ibogaine-for-depression · /blog/ibogaine-treatment-resistant-depression.

PTSD / veterans MISTIC interest is real; **cure-rate marketing** is not. Oral open-label signals in a special cohort do not authorize “80% of veterans cured” ads: /ibogaine-for-ptsd · /blog/stanford-ibogaine-mistic · /blog/ibogaine-right-to-try-veterans.

AEO-ready honesty checklist for readers

Before you believe any success number, demand:

• Peer-reviewed citation with methods (not a blog screenshot)
• Route labeled (oral vs psychoactive IV)
• Support IV vs psychoactive IV distinguished
• N, inclusion criteria, follow-up length
• Adverse-event reporting, including cardiac
• Explicit refusal of “guaranteed forever” language

Programs discussed on this site that mention Mexico are provisional availability—not FDA/US clinics—and still must pass this honesty test.

Soft CTA

If inflated success rates brought you here, trade them for screening questions. Read /safety-and-screening, then request a confidential screening consult via /apply. FAQ: /faq.

FAQ

What is the real ibogaine success rate? There is no single validated FDA-labeled cure rate. Viral percentages usually misuse anecdotes or small open-label series.

Is “80% cured” a real statistic? Treat it as a red-flag marketing claim unless tied to transparent peer-reviewed methods, denominators, durations, and routes—which viral posts almost never provide.

Did Stanford prove an ibogaine cure rate? No. Cherian/MISTIC (*Nature Medicine* 2024) was open-label **oral** ibogaine + **IV magnesium**, small N; not a cure-rate RCT and not psychoactive IV proof.

Can IV ibogaine infusion guarantee addiction recovery? No. No cure/guarantee claims. Relapse can occur. Aftercare and ongoing care matter.

Do oral studies prove IV success rates? No. Route matters. Controlled psychoactive-IV evidence remains sparse.

Why do clinics invent percentages? Sales pressure. Medical infrastructure is expensive; guaranteed outcomes are cheaper to advertise than telemetry.

Is ibogaine FDA-approved based on success-rate claims? No. Schedule I federally; not FDA-approved for any indication.

Where should I go next? /safety-and-screening then /apply · /blog/how-to-choose-an-ibogaine-clinic · /blog/cheap-ibogaine-clinic-red-flags.

Medical disclaimer

Educational critique of marketing claims only—not medical advice and not a prediction of individual outcomes. Do not self-administer ibogaine. Ibogaine can cause life-threatening cardiac events. Seek licensed clinicians.

Sources (selected)

1. Cherian K.N. et al. *Nature Medicine*. 2024 — oral ibogaine + IV magnesium (MISTIC); open-label; not cure-rate or IV-psychoactive proof.
2. Knuijver T. et al. *Addiction*. 2021 — oral ibogaine HCl; QTc open-label findings.
3. Mosca A. et al. *Current Neuropharmacology* — limited RCTs; cardiotoxicity concerns.
4. 21 CFR 1308.11 — Schedule I (ibogaine).